Literature DB >> 30148764

Peripartum Maternal Hepatitis B Care in a US Nationwide Data Set.

Matthew S Chang1, J Frank Wharam2, Fang Zhang2, Robert F LeCates2, Emma Morton-Eggleston2, Ruth E Tuomala3, Anna E Rutherford1, Muthoka L Mutinga1, Karin L Andersson4, Robert S Brown5, Chinweike Ukomadu1, Emily Oken2.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) screening during pregnancy is standard of care to prevent vertical transmission to infants, yet the mothers themselves may not receive appropriate follow-up. GOALS: Using a national database, we sought to determine rates of maternal peripartum follow-up with a HBV specialist and identify factors associated with a lack of follow-up.
MATERIALS AND METHODS: We identified women who delivered in 2000 to 2012 and were diagnosed with HBV according to International Classification of Diseases-9 codes using a national database (Optum) derived from commercial insurance claims with ∼46 million members ages 0 to 64 in all 50 states. Our primary outcome was follow-up during or after pregnancy with a HBV specialist (gastroenterology/infectious diseases).
RESULTS: The prevalence of HBV was 0.27% (2558/959,747 pregnancies), and median follow-up was 45 months. Only 21% of women had peripartum HBV specialist follow-up. On multivariable regression, predictors of peripartum follow-up at 1-year included younger age [odds ratio (OR), 0.97/y; 95% confidence interval (CI), 0.94, 0.99], Asian race/ethnicity (OR, 1.56 vs. white; 95% CI, 1.13, 2.17), and residing in the Northeast (OR, 1.70; 95% CI, 1.09, 2.66) and Midwest (OR, 1.73; 95% CI, 1.07, 2.81) versus West. Predictors of testing for HBV DNA and alanine aminotransferase at 1 year included Asian race (OR, 1.72; 95% CI, 1.23, 2.41), a primary care physician visit within 2 years of delivery (OR, 1.63; 95% CI, 1.19, 2.22), and peripartum HBV specialist follow-up within 1 year (OR, 15.68; 95% CI, 11.38, 21.60).
CONCLUSIONS: Maternal HBV specialist follow-up rates were extremely low in this large, diverse cohort representing all United States regions. Referral to a HBV specialist was the strongest predictor of appropriate postpartum HBV laboratory testing. Follow-up rates may be even lower in uninsured populations.

Entities:  

Year:  2019        PMID: 30148764      PMCID: PMC6387864          DOI: 10.1097/MCG.0000000000001122

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  26 in total

1.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

2.  Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics.

Authors:  Kevin C Ku; Jiayi Li; Nghi B Ha; Marina Martin; Vincent G Nguyen; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-12       Impact factor: 3.199

Review 3.  Use of geocoding and surname analysis to estimate race and ethnicity.

Authors:  Kevin Fiscella; Allen M Fremont
Journal:  Health Serv Res       Date:  2006-08       Impact factor: 3.402

4.  Evaluating area-based socioeconomic status indicators for monitoring disparities within health care systems: results from a primary care network.

Authors:  Seth A Berkowitz; Carine Y Traore; Daniel E Singer; Steven J Atlas
Journal:  Health Serv Res       Date:  2014-09-15       Impact factor: 3.402

5.  Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care.

Authors:  Blaire E Burman; Nizar A Mukhtar; Brian C Toy; Tung T Nguyen; Alice Hm Chen; Albert Yu; Peter Berman; Hali Hammer; Daniel Chan; Charles E McCulloch; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2013-09-20       Impact factor: 3.199

6.  The national Perinatal Hepatitis B Prevention Program, 1994-2008.

Authors:  Emily A Smith; Lisa Jacques-Carroll; Tanja Y Walker; Barry Sirotkin; Trudy V Murphy
Journal:  Pediatrics       Date:  2012-03-26       Impact factor: 7.124

7.  HIV screening in commercially insured patients screened or diagnosed with sexually transmitted diseases or blood-borne pathogens.

Authors:  Judy Ying Chen; Qiufei Ma; Francois Everhard; Irina Yermilov; Haijun Tian; Kenneth Hugh Mayer
Journal:  Sex Transm Dis       Date:  2011-06       Impact factor: 2.830

8.  Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer.

Authors:  Carine A Bellera; Gaëtan MacGrogan; Marc Debled; Christine Tunon de Lara; Véronique Brouste; Simone Mathoulin-Pélissier
Journal:  BMC Med Res Methodol       Date:  2010-03-16       Impact factor: 4.615

Review 9.  Screening for hepatitis B virus infection in pregnant women: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement.

Authors:  Kenneth Lin; John Vickery
Journal:  Ann Intern Med       Date:  2009-06-16       Impact factor: 25.391

10.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Sarah Schillie; Claudia Vellozzi; Arthur Reingold; Aaron Harris; Penina Haber; John W Ward; Noele P Nelson
Journal:  MMWR Recomm Rep       Date:  2018-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.